Literature DB >> 10573069

Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection.

M Toyoda1, A Petrosian, S C Jordan.   

Abstract

BACKGROUND: We have previously shown that the levels of anti-endothelial cell antibodies (AECA) determined by an enzyme immunoassay are elevated during cytomegalovirus (CMV) infection in cardiac and renal transplant recipients. In a separate study, high levels of AECA are associated with higher frequency of humoral allograft rejection (AR), chronic AR and lower 2 year allograft survival in cardiac transplant recipients. These results suggests that high levels of AECA produced during CMV infection may have a pathogenic role or be a risk factor for humoral AR, chronic AR and decreased allograft survival. Here we examined the reactivity of AECA against endothelial cells and other tissues to further characterize AECA induced by CMV infection.
METHODS: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis/Western blot analysis was performed.
RESULTS: The number and intensity of bands reactive with human umbilical vein ECs (HUVECs) increased during and after CMV infection. AECA(+) plasma reacted with multiple antigens expressed not only on endothelial cells but also on human fibroblasts, keratinocytes, platelets (PLs), peripheral blood mononuclear cells (PBMCs), Raji cells and THP-1 cells. Each individual's AECA(+) plasma showed different patterns of reactivity against these cells, whereas each plasma showed similar patterns of reactivity against ECs, PLs or peripheral blood mononuclear cells obtained from different individuals. AECA(+) plasma also showed a similar pattern of reactivity against HUVECs pretreated with/without interferon-gamma/tumor necrosis factor-alpha. The reactivity of preabsorbed sera with PLs significantly decreased against most reactive antigens expressed on PLs and other cell types.
CONCLUSIONS: (1) Antibodies induced by CMV infection are not specific to endothelial cells and appear to react with multiple cell types, (2) AECA (+) plasma react with multiple antigens expressed on various cell types that are primarily constitutively expressed on these cells and are not individual specific, (3) CMV-induced antibodies in AECA (+) plasma are primarily autoantibodies. These results suggest that the elevated AECA levels seen in CMV-infected transplant recipients may represent a polyclonal activation of humoral immune responses induced by CMV, which is of uncertain pathogenic significance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573069     DOI: 10.1097/00007890-199911150-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Authors:  Jon Kobashigawa; Maria G Crespo-Leiro; Stephan M Ensminger; Hermann Reichenspurner; Annalisa Angelini; Gerald Berry; Margaret Burke; Lawrence Czer; Nicola Hiemann; Abdallah G Kfoury; Donna Mancini; Paul Mohacsi; Jignesh Patel; Naveen Pereira; Jeffrey L Platt; Elaine F Reed; Nancy Reinsmoen; E Rene Rodriguez; Marlene L Rose; Stuart D Russell; Randy Starling; Nicole Suciu-Foca; Jose Tallaj; David O Taylor; Adrian Van Bakel; Lori West; Adriana Zeevi; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2011-03       Impact factor: 10.247

2.  Clinical and radiologic evaluation of cytomegalovirus-induced thrombocytopenia in infants between 1 and 6 months of age.

Authors:  Joon-Won Kang; Gee-Na Kim; Sun-Young Kim; Hee-Jin Kim; Eun-Sil Park; Jae-Young Kim; Young-Ho Lee
Journal:  Korean J Hematol       Date:  2010-03-31

3.  Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.

Authors:  Thomas Bachelet; Lionel Couzi; Vincent Pitard; Xavier Sicard; Claire Rigothier; Sébastien Lepreux; Jean-François Moreau; Jean-Luc Taupin; Pierre Merville; Julie Déchanet-Merville
Journal:  J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 10.121

4.  Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Authors:  Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali
Journal:  J Heart Lung Transplant       Date:  2009-03-14       Impact factor: 10.247

5.  Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.

Authors:  Bradley J Bloom; Mieko Toyoda; Anna Petrosian; Stanley Jordan
Journal:  Rheumatol Int       Date:  2006-12-13       Impact factor: 3.580

6.  Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection.

Authors:  Yao-Hsu Yang; Yu-Hui Huang; Ya-Hui Chuang; Chung-Min Peng; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  J Med Virol       Date:  2005-09       Impact factor: 2.327

Review 7.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

Review 8.  Advances in diagnosing and managing antibody-mediated rejection.

Authors:  Stanley C Jordan; Nancy Reinsmoen; Alice Peng; Chih-Hung Lai; Kai Cao; Rafael Villicana; Mieko Toyoda; Joseph Kahwaji; Ashley A Vo
Journal:  Pediatr Nephrol       Date:  2010-01-14       Impact factor: 3.714

9.  Lack of autoantibody production associated with cytomegalovirus infection.

Authors:  Beth C Marshall; Richard A McPherson; Eric Greidinger; Robert Hoffman; Stuart P Adler
Journal:  Arthritis Res       Date:  2002-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.